| __timestamp | Intra-Cellular Therapies, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 1488000000 |
| Thursday, January 1, 2015 | 87718074 | 1525000000 |
| Friday, January 1, 2016 | 93831530 | 2111000000 |
| Sunday, January 1, 2017 | 79419009 | 1848000000 |
| Monday, January 1, 2018 | 132166913 | 1213000000 |
| Tuesday, January 1, 2019 | 89124838 | 1010000000 |
| Wednesday, January 1, 2020 | 65782137 | 997000000 |
| Friday, January 1, 2021 | 88845513 | 967000000 |
| Saturday, January 1, 2022 | 134715000 | 838000000 |
| Sunday, January 1, 2023 | 180142000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc. have shown contrasting approaches to research and development (R&D) investments. From 2014 to 2023, Teva consistently outspent Intra-Cellular Therapies, with R&D expenses peaking in 2016 at over twice the amount of its competitor. However, Intra-Cellular Therapies has shown a remarkable growth trajectory, increasing its R&D spending by over 750% from 2014 to 2023. This upward trend highlights its commitment to innovation, despite being a smaller player. Meanwhile, Teva's R&D investment has seen a gradual decline, dropping by about 36% from its 2016 peak. This data provides a fascinating insight into how these companies prioritize innovation, with Intra-Cellular Therapies rapidly closing the gap in recent years.
Research and Development Investment: AstraZeneca PLC vs Teva Pharmaceutical Industries Limited
Research and Development Expenses Breakdown: Pfizer Inc. vs Intra-Cellular Therapies, Inc.
R&D Insights: How Alnylam Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Insights: How Teva Pharmaceutical Industries Limited and Geron Corporation Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Evotec SE
R&D Insights: How Intra-Cellular Therapies, Inc. and Jazz Pharmaceuticals plc Allocate Funds
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs TG Therapeutics, Inc.
Research and Development Investment: Intra-Cellular Therapies, Inc. vs Ultragenyx Pharmaceutical Inc.
Intra-Cellular Therapies, Inc. or PTC Therapeutics, Inc.: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Novavax, Inc.